A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease

Clinical trial NCT03033498 · COMPLETED

Trial details

NCT number: NCT03033498
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease (PD)

Start date: 2017-05-17
Primary completion: 2019-06-08
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.